ES75
TEAS SECTION 71 & 15 RECEIVED
10/06/2026
Voltar para busca
Dado oficial do USPTO
SIMULX
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
39
Atualização mais recente
11/06/2026
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
9, 42
Data de depósito
26/04/2019
Data de registro
23/06/2020
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
23/06/2020
Última transação
11/06/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
5
Tipo de titular
98
Localização do titular
FR
Examinador
CHISOLM, KEVON
Unidade examinadora
L30
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
S. F. (pessoa física)
LIXOFT
Representantes
M. Bud Nelson Simulations Plus, Inc.
Classificação técnica
Classes Nice
Classe 9Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 9
Downloadable clinical and preclinical trial simulation software; downloadable software used to process and interpret diagnostic test results; downloadable software for collectingstoring and processing dataimagesphotographsaudiovisual and audio-visual data; downloadable database management software; all these goods intended for simulation of clinical or preclinical trials or for individual optimization of therapeutic treatments
Classe 42
Pharmaceutical drug development servicesevaluationsassessments and research in the scientifictechnological and medical fields provided by engineers; engineers' services involving evaluationsestimatesresearch and reporting in scientifictechnological and medical fieldsdesign and development of drugs and medical devicesin the fields of modelingsimulationstatistics and data analysis; medical and scientific research in the field of clinical trial simulation; laboratory services for scientific and medical research; conducting clinical trials for others; research and development of new products for third parties; technical project studiesdrug and medical devices discovery servicesdesign and development of drugsmodelingsimulationstatistics and data analysis; design and development of computers and software; design and development of computers and software for treatment optimization; research relating to software; developmentdesigninstallationmaintenanceupdating and rental of software; programming for computers; providing information relating to medical research; assistance and consultinginstallationadministrationtroubleshooting of web and database applications in connection with the development of systemsdatabases and computer applications; conversion of computer programs and dataother than physical conversion; informationadvicesupport services in the nature of troubleshooting of computer software problems relating to any of the aforementioned services; all these services intended for simulation of clinical or preclinical trials or for individual optimization of therapeutic treatments
Publicações
Histórico de despachos e eventos da marca no USPTO.
39 publicações encontradas
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
23/06/2025
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
25/04/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
23/01/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
20/12/2024
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
02/11/2020
FICS
FINAL DISPOSITION NOTICE SENT TO IB
14/10/2020
FIMP
FINAL DISPOSITION PROCESSED
14/10/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
23/09/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
23/06/2020
CORN
CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
27/05/2020
LIMN
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
27/05/2020
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
17/04/2020
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
17/04/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/04/2020
PUBO
PUBLISHED FOR OPPOSITION
07/04/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
18/03/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/03/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
03/03/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
02/03/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
02/03/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
02/03/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
21/02/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
21/02/2020
ALIE
ASSIGNED TO LIE
18/02/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/02/2020
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
31/01/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
21/01/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
21/01/2020
NREP
NEW REPRESENTATIVE AT IB RECEIVED
08/11/2019
RFNT
REFUSAL PROCESSED BY IB
30/08/2019
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
14/08/2019
RFRR
REFUSAL PROCESSED BY MPU
14/08/2019
MAFR
APPLICATION FILING RECEIPT MAILED
20/07/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
17/07/2019
CNRT
NON-FINAL ACTION WRITTEN
16/07/2019
DOCK
ASSIGNED TO EXAMINER
16/07/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
16/07/2019
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
11/07/2019
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace SIMULX ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.